EVALUATION OF SMALLER CLINICAL TARGET VOLUMES AND PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TO INFORM FUTURE DIRECTIONS IN RADIATION TREATMENT PLANNING

被引：0
|
作者：
Hill, Jordan [1 ]
Tan, Yujue [1 ]
Tjong, Michael [2 ]
Youssef, Gilbert [3 ]
Aizer, Ayal [1 ]
Tanguturi, Shyam [1 ]
Shi, Diana [1 ]
Haas-Kogan, Daphne [1 ]
Huang, Raymond [1 ]
Wen, Patrick [3 ]
Rahman, Rifaquat [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Credit Valley Hosp, Trillium Hlth Partners, Mississauga, ON, Canada
[3] Dana Farber Canc Inst, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0324
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RADT-40
引用
收藏
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF SEX-BASED DIFFERENCES IN CLINICAL OUTCOMES AND TUMOR GENOMICS IN PATIENTS WITH NEWLY DIAGNOSED IDH-WILDTYPE GLIOBLASTOMA RECEIVING CHEMORADIATION
    Shi, Diana
    Lim-Fat, Mary Jane
    Nassar, Amin
    Woods, Jared
    Youssef, Gilbert
    Pisano, William
    Whorral, Sydney
    Allen, Marie
    Cagney, Daniel
    Tanguturi, Shyam
    Haas-Kogan, Daphne
    Aizer, Ayal
    McFaline-Figueroa, J. Ricardo
    Chukwueke, Ugonma
    Lee, Eudocia Quant
    Reardon, David
    Nayak, Lakshmi
    Bi, Wenya Linda
    Beroukhim, Rameen
    Ligon, Keith
    Alexander, Brian
    Wen, Patrick
    Rahman, Rifaquat
    NEURO-ONCOLOGY, 2021, 23 : 118 - 118
  • [42] IMPACT OF 18F-DOPA PET ON RADIOTHERAPY TARGET VOLUMES FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS; PRELIMINARY RESULTS OF A PHASE II DOSE-ESCALATION TRIAL
    Brinkmann, Debra
    Pafundi, Deanna
    Hunt, Christopher
    Lowe, Val
    Yan, Elizabeth
    Brown, Paul D.
    Zakhary, Mark
    Zhang, Yan
    Seaberg, Maasa
    Tseung, Hok Seum Wan Chan
    Sarkaria, Jann
    Laack, Nadia
    NEURO-ONCOLOGY, 2018, 20 : 225 - 225
  • [43] Postoperative Radiation Therapy Using a 5mm Clinical Target Volume Margin for Pediatric Patients with Newly Diagnosed Ependymoma. Treatment Results and Dose Volume Analysis
    Oshiro, Y.
    Mizumoto, M.
    Lucas, J.
    Tinkle, C.
    Upadhyaya, S.
    Jacola, L.
    Merchant, T.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S450 - S450
  • [44] Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment
    Kong, Xiao-Tang
    Nguyen, Nhung T.
    Choi, Yoon J.
    Zhang, Guicheng
    Nguyen, HuyTram N.
    Filka, Emese
    Green, Stacey
    Yong, William H.
    Liau, Linda M.
    Green, Richard M.
    Kaprealian, Tania
    Pope, Whitney B.
    Nghiemphu, P. Leia
    Cloughesy, Timothy
    Lassman, Andrew
    Lai, Albert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1195 - 1203
  • [45] PHASE II PILOT STUDYOF VELCADE® (BORTEZOMIB) IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME
    Kong, Xiao-Tang
    Green, Stacey
    Filka, Emese
    Green, Richard
    Yong, William
    Nghiemphu, Phioanh
    Cloughesy, Timothy
    Lai, Albert
    NEURO-ONCOLOGY, 2013, 15 : 78 - 79
  • [46] Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States
    Chen, Jigang
    Tong, Xin
    Han, Mingyang
    Zhao, Songfeng
    Ji, Linjin
    Qin, Yongkai
    He, Zilong
    Pan, Yuesong
    Wang, Chunhui
    Liu, Aihua
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [47] Radiologic progression types are treatment specific: An exploratory analysis of a phase 3 study of bevacizumab plus radiotherapy plus temozolomide for patients with newly diagnosed glioblastoma (AVAglio).
    Nowosielski, Martha
    Chinott, Olivier L.
    Radbrucht, Alexander
    Stockhammer, Guenther
    Garcia, Josep
    Revil, Cedric
    Nishikawa, Ryo
    Mason, Warren P.
    Henriksson, Roger
    Saran, Frank
    Bendszus, Martin
    Abrey, Lauren E.
    Cloughesy, Timothy Francis
    Wick, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Correlation of treatment effects on progression-free survival at 6 months (PFS-6) and overall survival (OS) in patients with newly diagnosed glioblastoma (GBM).
    Ye, X.
    Grossman, S. A.
    Desideri, S.
    Piantadosi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant Temozolomide
    Mendoza, Maria G.
    Azoulay, Melissa
    Chang, Steven D.
    Gibbs, Iris C.
    Hancock, Steven L.
    Pollom, Erqi L.
    Adler, John R.
    Harraher, Ciara
    Li, Gordon
    Gephart, Melanie Hayden
    Nagpal, Seema
    Thomas, Reena P.
    Recht, Lawrence D.
    Jacobs, Lisa R.
    Modlin, Leslie A.
    Wynne, Jacob
    Seiger, Kira
    Fujimoto, Dylann
    Usoz, Melissa
    von Eyben, Rie
    Choi, Clara Y. H.
    Soltys, Scott G.
    PRACTICAL RADIATION ONCOLOGY, 2023, 13 (03) : e239 - e245
  • [50] Low-grade astrocytoma, anaplastic oligodendroglioma or astrocytoma, and glioblastoma: The clinical trial portfolio of the EORTC Brain Tumor and Radiation Oncology Groups for newly diagnosed patients.
    Baumert, B.
    Stupp, R.
    Van den Bent, M. J.
    Erridge, A.
    Brandes, A.
    Pesce, G. A.
    Weber, D. C.
    Lacombe, D. A.
    Gorlia, T.
    Wick, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345